301 results on '"Clerkin, K."'
Search Results
2. Correlation Between the Subtype of Anti-HLA Donor Specific Antibodies and Rejection Assessed by Molecular Microscope
3. History of Malignancy and Rejection Outcomes Assessed by Molecular Microscope (MMDx)
4. Heart Transplantation in a Patient with Active Thyroid Cancer
5. Sublingual Microcirculation in Acute Mechanical Circulatory Support in Cardiogenic Shock
6. Epicardial and Microvascular CAV are Associated with Restrictive Physiology After Heart Transplantation
7. Implications of ABO Unmatched Donors on Cardiac Allograft Rejection Assessed by the Molecular Microscope (MMDx)
8. Molecular Microscope Findings in Low-Grade Histological Rejection: A Less Benign Reality Than Assumed
9. Racial and Ethnic Disparities in De-Novo Donor Specific Antibodies (DSA) and Rejection Rates in Heart Transplant Recipients Assessed by Molecular Microscope
10. Sex Differences in Allograft Rejection After Heart Transplantation (HT). Molecular Microscope (MMDx) Results
11. Microcirculatory Dysfunction in Cardiogenic Shock
12. Molecular Microscope (MMDx) Results in the Sensitized Heart Transplant Recipient
13. Association of Sex Mismatch with Allograft Rejection After Heart Transplantation (HT) - Molecular Microscope (MMDx) Results
14. Clinical Utility of Molecular Microscope Diagnostic System (MMDx) in Heart Transplant Recipients: Moving Towards a New Paradigm
15. Inflammatory Cardiomyopathies are Associated with Higher Rates of T-Cell Mediated Rejection. Molecular Microscope Results
16. Impact of MTOR Inhibitors on Heart Allograft Rejection Using Tissue-Based Gene-Expression Profiling. Molecular Microscope (MMDx) Results
17. Impact of Race Mismatch in Allograft Rejection After Heart Transplantation. Molecular Microscope (MMDx) Results
18. Does Multiorgan Transplantation Correlate with Reduced Rates of Rejection as Evaluated by the Molecular Microscope (MMDx)?
19. LVAD Bridge to Transplant and Rejection Assessed by Molecular Microscope
20. Impact of Epstein-Barr Virus (EBV) Mismatch on Gene-Expression Profiling (MMDx) and Rejection
21. Efficacy of Letermovir for CMV Prophylaxis in Heart Transplant Recipients with Moderate to High Risk CMV Serostatus
22. Molecular Microscope (MMDx) After COVID-19 Vaccination in Heart Transplant Recipients
23. Correlation Between High-Sensitivity Troponin-T and Molecular Microscope Results (MMDx)
24. Effects of Belatacept Therapy on Gene Expression Profiling and Rejection in Heart Transplant Recipients: A Molecular Microscope (MMDx) Evaluation
25. Correlation Between Peripheral Gene-Expression Profiling (GEP-Allomap) and Tissue Gene-Expression in T-Cell Mediated Rejection Detection
26. Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients
27. Is There A Correlation Between a High Immuknow Level and Increased Rates of Rejection? Insights from Molecular Microscope (MMDx)
28. What is Behind the Quilty Effect? Molecular Microscope Insights
29. Clinical Implications of Borderline Rejection Assessed by Molecular Microscope
30. Comparison of Microcirculatory Function in Patients with HeartMate 3 LVAD and Healthy Controls
31. Impact of MIC-A Antibodies on Antibody Mediated Rejection (ABMR). Molecular Microscope Results (MMDx)
32. Heart Failure Hospitalizations are Associated with Changes in Gut and Oral Microbiome
33. Correlation Between Donor-Derived Cell-Free DNA (dd-cfDNA) and Molecular Microscope (MMDx) in Heart Transplant Recipients
34. Impact of Cytomegalovirus (CMV) Mismatch on Rejection Assessed by Molecular Microscope (MMDx)
35. Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients
36. Diminished Microvascular Health in Heart Transplant Recipients Relative to Healthy Controls
37. Microcirculatory Dysfunction Across SCAI Stages of Cardiogenic Shock
38. (280) Comparison of Two Commercially Available Donor-Derived Cell-Free DNA Assays for Surveillance of Rejection in Heart Transplant Recipients
39. (230) The Effect of Preservation Modality on Myocardial Injury - A Single Blinded Study
40. (793) Validation of the Heartmate 3 Survival Risk Score in a Large Left Ventricular Assist Device Center
41. (1029) Donor-Derived Cell-Free DNA in Heart Transplant Recipients with a History of Congenital Heart Disease
42. (272) Isolated Microvascular Cardiac Allograft Vasculopathy is Associated with an Increased Risk of Death or Retransplantation
43. (494) The Utility and Characteristics of Cardiovascular Magnetic Resonance Imaging in Suspected Chronic Allograft Rejection
44. Visually Estimated Coronary Artery Calcium is an Independent Prognostic Marker Following Heart Transplantation
45. Impact of a Novel Social Worker Psychosocial Assessment (6D-SW) on Prospective Outcomes in HeartMate 3 (HM3) Patients
46. (175) Characteristics and Outcomes of Multiple Cardiac Re-Transplant Recipients
47. (765) Impact of Perioperative Sarcopenia and Dysphagia on LVAD Related Complications
48. A high-resolution melt curve toolkit to identify lineage-defining SARS-CoV-2 mutations
49. Long-Term Outcomes for Pediatric HT Patients Transitioning to Adult Care
50. The Impact of Preoperative Weight Loss on Survival Following Cardiac Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.